FDA inspection
Intas Pharmaceuticals Limited: FDA inspection ending May 12, 2023
FDA inspection 1206170 · Ahmedabad
Key facts
| Inspection ID | 1206170 |
|---|---|
| Firm | Intas Pharmaceuticals Limited |
| FEI number | 3003157498 |
| Address | 218p - Chacharwad, 458 - Matoda; Sarkhej Gandhi Nagar Highway |
| City | Ahmedabad |
| Fiscal year | 2023 |
| Inspection end date | May 12, 2023 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 662868 |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data